Our leadership team
Diverse leadership team with the experience to scale
Our passion is people, giving the best to our teams, patients and our partners.
Manuel O. Méndez
Chief Executive Officer
Ali Kiboro
Chief Financial Officer
Dr. Christian Fischer
Chief Scientific, Medical & Regulatory Affairs Officer
Sophie Bechu
Chief Operating Officer
Dr. Michael Hausmann
Chief Technology Officer
Viviane Montarnal
General Counsel & Compliance Officer
Steven Zuiderwijk
Chief Strategy & Marketing Officer
Mark Wheeler
Head of Customer Service & Support
David TenBarge
General Manager, Transfusion Business
Matt Howson
Chief Manufacturing Operations Officer, Clinical Business
Erika Abondano
Head of Human Resources
Trending Topics
Recent press, briefings and insights helping you stay informed on AliveDx news.
-
Alba Bioscience completes UK NHS Evergreen Sustainable Supplier Assessment and achieves Level 2
Alba Bioscience is pleased to have completed the UK National Health Service (NHS) Evergreen Sustainable Supplier Assessment. The Assessment is a self-assessment and reporting tool and resulted in Alba Bioscience receiving a Level 2: Comprehensive net zero targets and reporting
-
Launch of AliveDx Scientific Insights Center
We are excited to announce the launch of the AliveDx Scientific Insights Center on the AliveDx website. The Scientific Insights Center provides laboratorians and the medical community access to key published scientific communications. It offers valuable insights to help navigate
-
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray. The MosaiQ AiPlex CD is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows
Eysins, Switzerland, February 10th 2025 – AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Celiac Disease (CD) microarray. The MosaiQ AiPlex CD multiplex assay, which received IVDR-CE mark
-
AliveDx Suisse S.A. and Sedeer Medical Services and Trading Co. LLC Sign Distribution Agreement in Qatar
AliveDx Suisse S.A. and Sedeer Medical Services and Trading Co. LLC have signed a distribution agreement, which will enable Sedeer to distribute the MosaiQ® and LumiQ™ solutions in Qatar. The distribution agreement takes effect immediately. AliveDx is committed to expanding
-
AliveDx Expands Autoimmune Menu with IVDR-CE Marked MosaiQ AiPlex® CTDplus Multiplex Assay to Aid in Diagnosing Systemic Autoimmune Rheumatic Diseases and Streamline Laboratory Workflow
Eysins, Switzerland February 3rd, 2025 – AliveDx announces the receipt of IVDR-CE mark for its MosaiQ AiPlex® CTDplus multiplex assay. The multiplex assay enables a syndromic approach, simplifying laboratory workflow while delivering fast, actionable results to aid clinicians and laboratorians
-
MosaiQ AiPlex® Celiac Disease (CD) system now available in the EU market and other geographies that recognize the CE mark
We are excited to announce that our IVDR-CE marked MosaiQ AiPlex® Celiac Disease (CD) system is now available in the EU market and other geographies that recognize the CE mark (pending local registration in some countries). Celiac Disease is a
